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Abstract
Background: We have recently found a phenomenon that spontaneous regeneration of a hyaline cartilage-like
tissue can be induced in a large osteochondral defect by implanting a double-network (DN) hydrogel plug, which
was composed of poly-(2-Acrylamido-2-methylpropanesulfonic acid) and poly-(N, N’-Dimetyl acrylamide), at the
bottom of the defect. The purpose of this study was to clarify gene expression profile of the regenerated tissue in
comparison with that of the normal articular cartilage.
Methods: We created a cylindrical osteochondral defect in the rabbit femoral grooves. Then, we implanted the DN
gel plug at the bottom of the defect. At 2 and 4 weeks after surgery, the regenerated tissue was analyzed using
DNA microarray and immunohistochemical examinations.
Results: The gene expression profiles of the regenerated tissues were macroscopically similar to the normal
cartilage, but showed some minor differences. The expression degree of COL2A1, COL1A2, COL10A1, DCN, FMOD,
SPARC, FLOD2, CHAD, CTGF, and COMP genes was greater in the regenerated tissue than in the normal cartilage.
The top 30 genes that expressed 5 times or more in the regenerated tissue as compared with the normal cartilage
included type-2 collagen, type-10 collagen, FN, vimentin, COMP, EF1alpha, TFCP2, and GAPDH genes.
Conclusions: The tissue regenerated by using the DN gel was genetically similar but not completely identical to
articular cartilage. The genetic data shown in this study are useful for future studies to identify specific genes
involved in spontaneous cartilage regeneration.
Background
Articular (hyaline) cartilage is a highly organized soft
tissue [1]. Articular cartilage is frequently damaged due
to trauma, and treatment of damaged cartilage is a sig-
nificant health care concern. It has been a common
belief up to now that hyaline cartilage tissue cannot
spontaneously regenerate in vivo [2,3]. Therefore, the
most prevalent strategy to repair the articular cartilage
defect is to fill an osteochondral defect with a tissue-
engineered cartilage-like tissue or a cell-seeded scaffold
material [2,4-6]. However, recent studies have pointed
out various practical problems in this strategy, including
zoonosis transmission, the need for two-staged surgery,
a long period until weight bearing after implantation, an
enormous amount of money to establish a therapeutic
system [7-11]. Thus, functional repair of articular carti-
lage defects remains a major challenge in the field of
joint surgery and tissue regeneration medicine.
We have paid special attention to the clinical fact that
the fibrocartilage tissue can be regenerated in an osteo-
chondral defect by creating many small holes penetrat-
ing into the subchondral bone at the bottom of the
defect space in order to enhance bleeding from the
bone marrow [12]. Namely, the clot formed from bone
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can differentiate into cartilage tissues. In addition, recent
studies have shown that, in autologous chondrocyte
transplantation, quality of the tissue located just beneath
the transplanted cells significantly affects quality of the
regenerated cartilage [13-15]. In an ex vivo study, Engler
et al [16] reported that elasticity of the microenviron-
ment in a culture system directs stem-cell differentia-
tion. Therefore, we have considered that, if we implant
any bioactive elastic hydrogel at the bottom of an osteo-
chondral defect under conditions similar to in the
above-described multiple-penetration surgery, we may
be able to induce hyaline cartilage regeneration in vivo
in the defect space. We have focused on an originally
developed PAMPS/PDMAAm double-network (DN)
hydrogel [17,18], which was composed of poly-(2-Acry-
lamido-2-methylpropanesulfonic acid) (PAMPS) and
poly-(N, N’-Dimetyl acrylamide) (PDMAAm). In DN
gel, the two independently cross-linked polymer net-
works are physically entangled with each other. The
PAMPS network in this DN gel is negatively charged
and has a sulphonic acid base, being similar to proteo-
glycans in normal cartilage. This bioactive DN gel has
the elastic modulus of 0.20 MPa [19,20]. In addition, the
PAMPS/PDMAAm DN gel surface can enhance differ-
entiation of chondrogenic ATDC5 cells into chondro-
cytes in the in vitro condition [21,22].
Thus, we have recently found a noteworthy phenom-
enon that, when we implant the PAMPS/PDMAAm DN
hydrogel plug at the bottom of an osteochondral defect
in the rabbit so that a 2- to 3-mm deep vacant space is
intentionally left in the defect, a hyaline cartilage-like tis-
sue rich in type-2 collagen and proteoglycan is sponta-
neously regenerated in vivo in the defect within 4 weeks
[21]. Because this phenomenon has a potential that may
lead to development of a novel therapeutic method to
spontaneously regenerate a hyaline cartilage-like tissue,
we should perform multidisciplinary evaluations of the
quantity and quality of the regenerated tissue to increase
a scientific database of this phenomenon. We have per-
formed histological and immunohistological evaluations
[23,24]. However, no biomechanical, biochemical, and
genetic studies to evaluate the regenerated tissue have
n o tb e e nr e p o r t e da so fy e t .T h u s ,t h ep r e s e n ts t u d y
using DNA microarray has been conducted to genetically
clarify what gene expression is induced in the regenerated
t i s s u eb yt h eD Ng e li m p l a n t a t i o n ,a n dt oa s kw h e t h e r
the regenerated tissue is genetically identical to the nor-
mal articular cartilage. The purpose of the present in vivo
s t u d yu s i n gt h em i c r o a r r a ya n a l y s i si st oc l a r i f yag e n e
expression profile of the cartilage-like tissue sponta-
neously regenerated by using the PAMPS/PDMAAm DN
gel in comparison with the normal articular cartilage.
Methods
1) Hydrogel preparation
The PAMPS/PDMAAm DN gel was synthesized using the
previously reported two-step sequential polymerization
method [17]. After polymerization, the PAMPS-PDMAAm
DN gel was immersed in pure water for 1 week and the
water was changed 2 times every day to remove any un-
reacted materials. From the PAMPS/PDMAAm DN gel,
we created cylindrical plugs having a 4.5-mm diameter
and an 8-mm length.
2) Study design
A total of 17 mature female Japanese white rabbits weigh-
ing 3.6 ± 0.5 kg were used in this study. Animal experi-
ments were carried out in the Institute of Animal
Experimentation, Hokkaido University School of Medicine
under the Rules and Regulation of the Animal Care and
Use Committee, Hokkaido University School of Medicine.
Fourteen of the 17 rabbits underwent the previously
reported operation [21] in the bilateral knees under intra-
venous anesthesia (pentobarbital, 25 mg/kg) and sterile
conditions. Briefly, we created a cylindrical osteochondral
defect having a diameter of 4.3-mm and a depth of
10.0 mm in the femoral groove of the patellofemoral joint,
using a drill. Then, we implanted the DN gel plug into the
defect so that a defect having approximately 2-mm depth
from the articular surface remained in place after surgery
(Figure 1). The depth of 2 mm was chosen because this
depth was the most effective to induce the spontaneous
cartilage regeneration in our previous preliminary study
[21]. The incised joint capsule and the skin wound were
closed in layers with 3-0 nylon sutures, and an antiseptic
spray dressing was applied. Postoperatively, each animal
was allowed unrestricted activity in a cage (310 × 550 ×
320 mm) without any joint immobilization. Seven animals
were sacrificed at 2 and 4 weeks after surgery, respectively.
Figure 1 How to induce cartilage regeneration. A cylindrical
osteochondral defect having a diameter of 4.3-mm was created in
the femoral groove. Then, a DN gel plug was implanted into the
defect so that a defect having approximately 2-mm depth from the
articular surface remained in place after surgery.
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file. The tissue regenerated in the defect was harvested
from the 5 rabbits with a surgical knife and a sharp cullet,
and mixed into a tissue sample. From the tissue sample,
mRNAs were then extracted. In the remaining 2 rabbits, a
distal portion of the femur was resected and fixed in a
10% neutral buffered formalin solution. Then, the same
histological and immunohistochemical examinations as
reported in our previous study [21] were performed to
confirm the expression of proteoglycans and type-2 col-
lagen in the cells and the matrix. On the other hand, using
the remaining 3 untreated mature rabbits, the normal
articular cartilage was harvested from the bilateral femurs
in the same manner. Gene expression profiles in the tis-
sues regenerated at 2 and 4 weeks were analyzed with use
of custom-made DNA microarray, and compared with a
profile of the normal cartilage. The microarray analyses
were repeated 3 times using the same mRNA sample to
confirm the reproducibility.
3) Analysis with microarray
RNA isolation and labelling
Total RNA was isolated using the RNA isolation kit (Qia-
gen Inc., MD, USA), according to the manufacturer’s
instructions. After monitoring the stability and quantity
of the RNA with a 2100 Bioanalyzer (Agilent Technolo-
gies, CA, USA), fluorescence-labelled cDNA was synthe-
sized by direct incorporation of Cy3-dUTP or Cy5-dUTP
(GE Healthcare Bio-science, Little Chalfont, UK) during
random hexamer-primed reverse transcription, using
20 μg of total RNA and the CyScribe First-strand cDNA
labelling kit (GE Healthcare Bio-Science).
Hybridization and signal detection
Custom oligonucleotide microarrays were obtained from
Combimatrix Corp. (Mukilteo, WA, USA). The probes
were designed to detect the directly labelled mRNA from
8697 genes which contain 2153 genes from EST library
constructed from cartilage tissue of Japanese white rabbits
[25] and 6544 genes from the NCBI database: data for
some of the genes could not be used in the microarrays,
because of their short open reading frames. The probes
were loaded on a microarray at least in triplicate.
The microarray was pre-hybridized for 1 hour at 42°C
in a solution containing 5 × SSC, 0.1% SDS, 400 mg ml
-1
bovine serum albumin, and 100 ng μl
-1 salmon sperm
DNA. After being washed three times with double dis-
tilled water for 2 min, the microarray was hybridized
with heat-denatured labelled cDNA in 5 × SSC, 0.1%
SDS and 10% formamide for 16 h at 42°C. The array was
then washed with 5 × SSC and 0.05% SDS for 4 min, with
0.5 × SSC for 1 min, and with 2 × PBS for 4 min, and
fluorescent images of the Cy3 and Cy5 dye channels were
obtained using a GenePix 4000B (Axon Instruments, CA,
USA). The signal intensity of each spot and its local
background were determined using an Array-Pro Analy-
zer (Media Cybernetics, MD, USA). The net intensity
was calculated by subtracting the mean intensity of all
pixels within the local background area from the mean
intensity of all pixels within each spot area.
Results
Histological and immunohistological findings of the
regenerated tissue
At 2 weeks, the defect treated with the DN-gel implanta-
tion was filled with a blood clot, which was formed by
spontaneous bleeding from the bone marrow after surgery.
In the blood clot, 2 triangular zones rich in cells were
observed close to the bony wall of the defect and the
implanted gel. A cartilage-like tissue rich in proteoglycan
and type-2-collagen appeared in the triangular zones
(Figure 2). At 4 weeks, the defect was filled by a sufficient
volume of proteoglycan-rich tissue with regenerated sub-
chondral bone tissue. The immunohistological observation
showed that the type-2 collagen was abundantly expressed
in the proteoglycan-rich tissue.
General gene profile of the normal and regenerated
tissues
Of the 8697 probe sets arrayed on the DNA chips, the
number of genes which showed the expression level
Figure 2 Regenerated hyaline-cartilage tissues (low
magnification, x2). A and B: At 2 weeks, symmetrical triangular
zones rich in cells were observed in a localized zone close to the
bony wall and the implanted gel in the defect. A cartilage-like tissue
rich in proteoglycan (A: Safranin-O stain) and type-2-collagen (B:
Immunostaining) appeared in the triangular zones. C and D: At 4
weeks, the defect was filled with a sufficient volume of the tissue
rich in proteoglycan (C: Safranin-O stain) and type-2-collagen (D:
Immunostaining). E, F, G, and H: Control (untreated) specimens at 2
and 4 weeks. The defects were filled with fibrous and osseous
tissues.
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-3 of that of the greatest expressed gene
was 8488 in the normal cartilage, while it was 8479 and
8625 in the regenerated cartilage harvested at 2 and
4 weeks, respectively. These genes were used for the fol-
lowing analyses. These genes were functionally classified
into 7 categories based on their biological roles, using
the application AmiGO (http://www.godatabase.org).
Table 1 shows the classification of the most highly
expressed 300 genes in the normal cartilage and the
regenerated tissues harvested at 2 and 4 weeks. The rate
of each category was completely identical between the
regenerated tissues harvested at 2 and 4 weeks. The
classification profile of the regenerated tissues was
macroscopically similar to that of the normal cartilage,
but showed some minor differences (Table 1); e.g., the
rate of the cell growth and/or maintenance-related genes
was greater (1.7 folds) in the regenerated tissues (12%)
than in the normal cartilage (7%). Table 2 shows a list of
t h em o s th i g h l ye x p r e s s e d3 0g e n e si nt h en o r m a lc a r t i -
lage and the regenerated tissues. Not only type-2 col-
lagen-related genes but also Matrix Gla protein (MGP),
Signalosome subunit 6 (SN6), and Pleckstrin homology
domain (PH domain) genes were seen in each list. On
the other hand, Transcription Factor CP2 (TFCP2) and
Cbp/p300-interacting Transactivator (CITED) genes
w e r ef o u n do n l yi nt h el i s to nt h er e g e n e r a t e dt i s s u e s
(Table 2).
Cartilage-specific gene profile of the normal and
regenerated tissues
Collagen-related genes
In the normal cartilage, collagen genes of type-2A1, 3A1,
1A2, 11A2, and 10A1 (COL2A1, COL3A1, COL1A2,
COL11A2, and COL10A1) were dominantly expressed
(Figure 3). In the regenerated tissues, the same genes
were dominantly expressed at each period. The expres-
sion degrees of COL2A1, COL1A2, and COL10A1 genes
in the regenerated tissues were twice or more as large as
those in the normal cartilage.
Proteoglycan-related genes
In the normal cartilage, proteoglycan 4 (PRG4), proline-
arginine-rich end leucine-rich repeat protein (PRELP),
decorin (DCN), fibromodulin (FMOD), glypican 6 (GPC6),
biglycan (BGN), syndecan 2 (SDC2), and aggrecan genes
were dominantly expressed (Figure 4). In the regenerated
tissues, the same genes were dominantly expressed at each
period. The expression degrees of DCN and FMOD genes
in the regenerated tissues were twice or more as large as
those in the normal cartilage, and the expression degree of
GPC6 gene in the regenerated tissues was quarter as little
as those in the normal cartilage.
Genes related to noncollagen/nonproteoglycan constituents
In the normal cartilage, MGP, fibronectin 1 (FN1), chiti-
nase 3-like 1 (CH13L1), secreted protein acidic and rich in
cysteine (SPARC), procollagen-lysine 2-oxoglutarate 5-
dioxygenase 2 (PLOD2), chondroadherin (CHAD), carti-
lage transformation growth factor (CTGF), and cartilage
oligomeric matrix proteins (COMPs) genes were domi-
nantly expressed (Figure 5). In the regenerated tissues, the
same genes were dominantly expressed at each period.
The expression degrees of SPARC, FLOD2, CHAD,
CTGF, and COMPs genes in the regenerated tissues were
twice or more as large as those in the normal cartilage.
Histological and immunohistological findings of the
regenerated tissue
We determined the relative expression level of each gene
in the regenerated tissues to the normal cartilage. At 2
and 4 weeks, 307 and 270 genes, respectively, were
expressed 5 times or more as compared with the normal
cartilage. The functional classification profiles of these
genes were identical between the 2 periods (Table 3).
Major categories were comprised of protein metabolism-
related genes (26%), cell growth- and maintenance-
related genes (20-21%), and cell communication/signal
transduction-related genes (10-11%). Minor categories
(2-5%) included transport-related genes, energy pathway-
related genes, nucleobase regulation-related genes, and
Table 1 Functional classification of the most highly expressed 300 genes in the normal cartilage and the regenerated
tissues harvested at 2 and 4 weeks
Functional Normal Regenerated tissue Regenerated tissue
Categories Cartilage (2 weeks) (4 weeks)
Protein metabolism 42 (14.0%) 36 (12.0%) 37 (12.3%)
Cell communication/Signal transduction 25 (8.3%) 24 (8.0%) 23 (7.7%)
Cell growth and/or maintenance 21 (7.0%) 36 (12.0%) 37 (12.3%)
Regulation of nucleobase 14 (4.7%) 16 (5.3%) 15 (5.0%)
Energy pathways/Metabolism 14 (4.7%) 11 (3.7%) 13 (4.3%)
Immune response 12 (4.0%) 9 (3.0%) 10 (3.3%)
Transport 8 (2.6%) 8 (2.7%) 10 (3.3%)
Unknown 164 (54.7%) 160 (53.3%) 155 (51.8%)
(Unit: genes).
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genes were unclassified. Table 4 shows a list of the top 30
genes that were expressed 5 times or more as compared
with the normal cartilage. The list includes type-2 and
type-10 collagen genes, which are related to matrix col-
lagen, as well as FN, vimentin, and COMP genes, which
are related to noncollagen/nonproteoglycan constituents
of the extracellular matrix. The list also involves elonga-
tion factor 1 alpha (EF1alpha) and TFCP2 genes, which
are classified as regulation-related genes, as well as gly-
ceraldehyde-3-phosphate dehydrogenase (GAPDH) gene,
which is categolized as energy metabolism-related gene
(Table 4).
In addition, 145 and 121 genes were expressed one fifth
or less as compared with the normal cartilage at 2 and 4
weeks, respectively. The functional classification profiles
of the 145 and 121 genes were found to be almost similar
(Table 5): The rate of each category was less than 10%,
while functions of 63-66% of the genes were unclassified.
The bottom 30 genes which were expressed in the regen-
erated tissues one fifth or less as compared with the nor-
mal cartilage at each period were listed in Table 6.
Table 2 A list of known genes in the top 30 genes most highly expressed in the normal cartilage and the regenerated
tissues harvested at 2 and 4 weeks
Tissue Place Gene
Regenerated (2 Wks.) 2 Pro alpha1 type II collagen
3 Signalosome subunit 6
4 Luteinizing hormone beta polypeptide
6 Pro alpha1 type II collagen
8 COL3A1 protein isoform 9
12 Proteoglycan 4
14 Peroxisome proliferator-activated receptor delta (PPARD)
18 Pleckstrin homology domain containing, family A member 4
21 Transcription factor CP2
22 Cbp/p300-interacting transactivator
23 Type II Collagen
27 COL3A1 protein, transcript variant 3
28 Matrix Gla protein
Regenerated (4 Wks.) 1 Luteinizing hormone beta polypeptide
2 COL3A1 protein isoform 9
3 Pro alpha1 type II collagen
5 Pro alpha1 type II collagen
6 Signalosome subunit 6
13 Type II Collagen
14 Cbp/p300-interacting transactivator
15 Transcription factor CP2
16 Proteoglycan 4
19 Matrix Gla protein
20 COL3A1 protein, transcript variant 3
22 Matrix Gla protein
23 Tetraspan NET-6
Normal cartilage 1 T-cell Receptor gamma chain V1.1
2 Mindbomb homolog 2
3 Signalosome subunit 6
10 Pleckstrin homology domain containing, family A
15 Matrix Gla protein
20 Spectrin, beta, non-erythrocytic 2
21 Glutathione synthetase
22 Peroxisome proliferator-activated receptor delta
23 Brain protein I3
29 Pro alpha1 type II collagen
30 Immunoglobulin heavy chain VDJC-alpha (IgA)
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This study clarified a gene expression profile of the car-
tilage-like tissue regenerated by using the PAMPS/
P D M A A mD Ng e li nc o m p a r i s o nw i t ht h a to ft h en o r -
mal mature cartilage. The present study showed that
gene expression profiles of the tissues spontaneously
regenerated at both 2 and 4 weeks by using the
PAMPS/PDMAAm DN gel were similar to the normal
cartilage. Type-2 collagen-related genes, MGP, SN6, and
PH domain genes were highly expressed in both the tis-
sues. Type-2 collagen-related genes are the most essen-
tial markers that upregulate upon hyaline cartilage
differentiation, and MGP is a calcification inhibitor in
the cartilage [26]. SN6 and PH domain genes were
highly expressed within all the tissues. Roles of these
molecules in chondrogenesis have been unknown. How-
ever, we should note that mammalian constitutive
photomorphogenesis 9 SN6 connects signaling with the
ubiquitin-mediated proteasome degradation pathway
and is implicated in cell cycle regulation and DNA
damage response [27], and that PH domains play a role
in recruiting proteins to different membranes and enable
proteins to interact with other components of the signal
transduction pathways [28]. Therefore, the present study
s u g g e s t e dt h a tt h er e g e n e r a ted cells were genetically
Figure 3 Expression of collagen-related genes.I nt h e
regenerated tissues, the same genes were dominantly expressed at
each period, while the expression degree of collagen (COL) type-
2A1, 1A2, and 10A1 genes was obviously greater (twice or more) in
comparison with the normal cartilage.
Figure 4 Expression of proteoglycan-related genes.I nt h e
regenerated tissues, the same genes were dominantly expressed at
each period, while the expression degree of DCN and FMOD genes
was obviously greater (twice or more) in comparison with the
normal cartilage, and the GPC6 gene was expressed to a lesser
degrees (one-fourth). (PRG4: proteoglycan 4; PRELP: proline-arginine-
rich end leucine-rich repeat protein; DCN: decorin; FMOD:
fibromodulin; GPC6: glypican 6; BGN: biglycan; SDC2: syndecan 2;
AGC: aggrecan; CSPG2: chondroitin sulfate proteoglycan 2; SGCB:
sarcoglycan beta; SDC4: syndecan 4).
Figure 5 Expression of genes of noncollagen/nonproteoglycan
constituents. In the regenerated tissues, the same genes were
dominantly expressed at each period, while the expression degree
of SPARC, FLOD2, CHAD, CTGF, and COMPs genes was obviously
greater (twice or more) in comparison with the normal cartilage.
(MGP: matrix G protein; FN1: fibronectin 1; CH13L1: chitinase 3-like
1; SPARC: secreted protein acidic and rich in cysteine; procollagen-
lysine; PLOD2: procollagen-lysine 2-oxoglutarate 5-dioxygenase 2;
CHAD: chondroadherin; CTGF: cartilage transformation growth
factor; COMP: cartilage oligomeric matrix protein; HAPLN1:
hyaluronan and proteoglycan link protein 1; LAMA: Laminin subunit
alpha-4; CH13L2: chitinase 3-like 2: CHID1: chitinase 1; CILP2:
cartilage intermediate layer protein 2; EFEMP2: EGF-containing
fibulin-like extracellular matrix protein 2).
Table 3 Functional classification of 307 and 270 genes
that were expressed in the regenerated tissues harvested
at 2 and 4 weeks, respectively, 5 times or more as
compared with the normal cartilage
Functional categories 2 weeks 4 weeks
Protein metabolism 79 (25.7%) 69 (25.7%)
Cell growth and/or maintenance 63 (20.5%) 54 (20.0%)
Cell communication/Signal transduction 32 (10.4%) 29 (10.7%)
Transport 14 (4.6%) 13 (4.8%)
Energy pathways/Metabolism 12 (3.9%) 9 (3.3%)
Regulation of nucleobase 10 (3.3%) 9 (3.3%)
Immune response 5 (1.6%) 6 (2.2%)
Unknown 92 (30.0%) 81 (30.0%)
(Unit: genes).
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Histological and immunohistochemical examinations in
the present study showed that type-2 collagen and pro-
teoglycan molecules were highly expressed in the
regenerated cells and matrix at 2 and 4 weeks, respec-
tively. These results were supported by our previous
study [21]. Additionally, we took notice of the immune-
related genes in Tables 1 and 3. The ratio of immune-
related gene expression was identical among the normal
cartilage and the regeneration tissues. These facts
implied that the implantation of the PAMPS/PDMAAm
DN gel plug did not induce any immune reactions in
the rabbit, although it was a foreign body.
Secondly, the present study demonstrated that the carti-
lage marker gene profile of the tissues regenerated by the
DN gel implantation was similar to that of the normal car-
tilage, concerning the types of highly expressed genes.
Genetically, we can regard the regenerated tissue as the
hyaline cartilage. However, the gene profile of the regener-
ated tissue has some differences concerning the quantity
of each expression level. In the regenerated tissues, the
expression degree of COL2A1, COL1A2, and COL10A1
genes in the genes encoding collagens, DCN and FMOD
Table 4 A list of the top 30 genes that were expressed in the regeneration tissues harvested at 2 or 4 weeks 5 times
or more as compared with the normal cartilage
Place 2W 4W
1 elongation factor 1 alpha elongation factor 1 alpha
2 osteonectin glyceraldehyde-3-phosphate dehydrogenase
3 glyceraldehyde-3-phosphate dehydrogenase osteonectin
4 collagen type X collagen type X
5 collagen type X transcription factor CP2
6 transcription factor CP2 collagen type X
7 cystatin C cystatin C
8 collagen type III alpha 1 collagen type III alpha 1
9 unknown osteonectin
10 osteonectin osteonectin
11 vimentin unknowm
12 osteonectin unknowm
13 vimentin C-type lectin superfamily member 1
14 unknown vimentin
15 ubiquitin B hemoglobin, beta
16 unknown COMP
17 C-type lectin superfamily member 1 Vimentin
18 fibronectin ribosomal protein L17
19 tartrate-resistant acid phoshatase COMP
20 ribosomal protein S8 unknowm
21 ribosomal protein L17 ubiquitin B
22 unknown fibronectin
23 cartilage oligomeric matrix protein ribosomal protein S8
24 ribosomal protein L17 osteonectin
25 collagen type X collagen type X
26 pP47 protein decorin
27 unknown ribosomal protein L17
28 23 kD highly basic protein ribosomal protein S18
29 ribosomal protein S18 unknowm
30 osteonectin Ribosomal protein L18A
Table 5 Functional classification of 145 and 121 genes
that were expressed in the regenerated tissues harvested
at 2 and 4 weeks, respectively, one fifth or less as
compared with the normal cartilage
Functional categories 2 weeks 4 weeks
Cell communication/Signal transduction 12 (8.3%) 12 (9.9%)
Energy pathways/Metabolism 11 (7.6%) 8 (6.6%)
Immune response 11 (7.6%) 8 (6.6%)
Regulation of nucleobase 8 (5.5%) 8 (6.6%)
Transport 4 (2.7%) 4 (3.3%)
Protein metabolism 2 (1.4%) 3 (2.5%)
Cell growth and/or maintenance 2 (1.4%) 1 (0.8%)
Unknown 95 (65.5%) 77 (63.7%)
(Unit: genes).
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FLOD2, CHAD, CTGF, and COMPs genes in the genes
encoding noncollagen/nonproteoglycan constituents of
the extracellular matrix were obviously greater in compari-
son with the normal cartilage. COL10A1 is an important
marker of prehypertrophic and hypertrophic chondro-
cytes. DCN is produced predominantly by mesenchymal
stem cells, binds to type-2 collagen, and is involved in the
control of fibrillogenesis [29]. FMOD interacts with type-1
and type-2 collagen fibrils and inhibits fibrillogenesis
in vitro, and may participate in the assembly of the extra-
cellular matrix in vivo [30]. SPARC modulates synthesis as
well as turnover of the collagenous extracellular matrix.
[31]. PLOD2 is regulated with total collagen synthesis [32].
CHAD binds to two sites on type-2 collagen. Both CHAD
and collagen interact with chondrocytes, partly via the
same receptor, but give rise to different cellular responses
[33]. CTGF is an important growth factor that coordinates
chondrogenesis [34]. COMPs are prominent in cartilage;
however, it is also present in tendon and binds to type-1
and type-2 collagens with high affinity [35,36], although
the functions is not sufficiently clarified. Therefore, the
above-described results suggested that various genes con-
cerning condrogenesis were strongly enhanced in the tis-
sues spontaneously regenerated by implanting the DN gel.
However, it is unclear whether such gene expression
profile is specific characteristics of the cartilage tissue
regenerated by the DN gel implantation or common char-
acteristics of cartilage tissues regenerated with tissue-engi-
neering techniques, because gene expression profiles of
the tissue-engineered cartilage tissues have not been clari-
fied as of yet.
Table 3 and Table 5 show a category of the genes that
were different in the expression level between the normal
cartilage and the tissues regenerated by the DN gel implan-
tation. Specifically, we paid attention to the fact that pro-
tein metabolism-related genes of more than 60 (26%) and
cell growth-related genes of more than 40 (20%) were
Table 6 A list of the bottom 30 genes that were expressed in the regeneration tissues harvested at 2 or 4 weeks one
fifth or less as compared with the normal cartilage at each period
Place 2W 4W
1 Clusterin translokin
2 unknown stromal interaction molecule 2
3 Unknown Lactase phlorizin hydrolase
4 5-hydroxytryptamine (serotonin) receptor 7 unknown
5 Lactase phlorizin hydrolase unknown
6 N207 immunoglobulin mu heavy chain VDJ region unknown
7 translokin CG32425-PA
8 NFI-B N207 immunoglobulin mu heavy chain VDJ region
9 unknown unknown
10 unknown unknown
11 unknown unknown
12 unknown clusterin
13 unknown CGMP-dependent protein kinase I
14 Chloride channel unknown
15 zinc finger protein 282 NFI-B
16 unknown unknown
17 upregulated during skeletal muscle growth 5 RAG-2
18 PiUS zinc finger protein 282
19 stromal interaction molecule 2 heat shock 70 kDa protein 5
20 unknown unknown
21 Myosin light chain kinase 2 PiUS
22 unknown calnexin
23 nudix -type motif 9 G-protein coupled receptor 48
24 TNF superfamily, member 2 P235 immunoglobulin mu heavy chain VDJ region
25 unknown Myosin light chain kinase 2
26 ceruloplasmin Proteolipid protein
27 unknown unknown
28 unknown unknown
29 unknown unknown
30 mitochondrial trifunctional protein, beta subunit mitochondrial trifunctional protein, beta subunit
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Page 8 of 11highly expressed 5 times or more than the normal articular
cartilage in the regenerated cartilage tissue. We carefully
checked these up-regulated genes, and did not find any
genes related to tumor or abnormal cell growth, such as
alpha-fetoprotein, beta-2-microglobulin, beta-HCG,
Bladder tumor antigen, CA15-3, CA19-9, CA27, CA29,
CA72-4, CA125, calcitonin, carcinoembryonic antigen,
chromogranin A, epidermal growth factor receptor,
hormone receptors, HER2, human chorionic gonadotropin,
immunoglobulins, neuron-specific enolase, NMP22, pros-
tate-specific antigen, prostatic acid phosphatase, prostate-
specific membrane antigen, S-100, TA-90, thyroglobulin,
and etc. These results indicated that the genes up-regulated
in the present study were not related to differentiation to
tumor cells, but to the chondrocyte itself. In addition, the
gene profile shown in the present study suggested that the
regeneration process continued over the 4 week period. In
the histological findings, we observed a little unrepaired
lesion in the middle of the regenerated cartilage. The 4
week period after implantation is considered to be insuffi-
cient to complete a comprehensive osteochondral regen-
eration in adult rabbit knees with a full-thickness defect.
This information will contribute to an increase of basic
database to create an effective protocol for regeneration of
cartilage in the near future.
In the present study, we found that TFCP2, CITED,
and elongation factor-1 (EF-1) alpha were highly
expressed in the cartilage tissue regenerated by the DN
gel implantation in comparison to the normal cartilage. It
is known that TFCP2 regulates genes involved in devel-
opment of mesenchymal stem cells [37] and CITED con-
trols the transcription activity of Cart1 involved in
skeletal development [38]. Therefore, we speculate that
TFCP2 and CITED may play an important role in the
cartilage regeneration induced by the DN gel implanta-
tion. In addition, it has been reported that EF-1 alpha is
related to protect a cell from endoplasmic reticulum
stress [39], which reduces both chondrocyte growth and
matrix expression and induces chondrocyte apoptosis
[40]. Therefore, we speculate that EF-1 alpha also may
contribute to the DN gel-induced cartilage regeneration
by suppressing endoplasmic reticulum stress.
In the list of the top 30 genes that were expressed in the
regenerated tissues 5 times or more as compared with the
normal cartilage, we have taken notice of fibronectin and
vimentin. It has been known that fibronectin plays a criti-
cal role in prechondrogenic condensation in the early
stage of chondrogenesis [41] and that vimentin contributes
to the maintenance of the chondrocyte phenotype [42].
Therefore, the highy expressed fibronectin and vimentin
may contribute to the spontaneous cartilage regeneration
by stimulating the condensation process of mesenchymal
stem cells and maintaining cartilage phenotype, respec-
tively. In addition, we also found that GAPDH, which
plays a significant role in glycolysis, was highly expressed
in the regenerated cartilage in comparison with the nor-
mal cartilage. It is known that the energy is supplied by
glycolysis in a hypoxia environment rather than by mito-
chondrial respiration [43]. Escoubet et al [44] reported
that hypoxia increases GAPDH transcription in rat alveo-
lar epithelial cells. Therefore, the high expression of
GAPDH observed in the present study implies that glyco-
lysis is enhanced in the cartilage regeneration induced by
the DN gel implantation in order to respond to a high
energy demand in a low-oxygen environment.
Finally, the present study has demonstrated that the tis-
sue regenerated in vivo by using the PAMPS/PDMAAm
DN gel can be genetically regarded as the hyaline cartilage,
although it has some minor differences from the normal
cartilage. Therefore, we can conclude that spontaneous
articular cartilage regeneration can be induced in vivo by
using the PAMPS/PDMAAm DN gel. However, biome-
chanical and biochemical studies are needed to develop a
novel therapeutic method to induce the spontaneous
articular cartilage regeneration. The present study includes
a few limitations. First, we did not perform statistical ana-
lyses. Secondly, we did not evaluated functions of the
highly expressed genes. Further studies are needed to clar-
ify genetic mechanisms of the spontaneously regenerated
cartilage. However, the genetic data shown in this study
are considered to be useful for future studies to identify
specific genes involved in spontaneous cartilage regenera-
tion and to make their mechanisms clear.
Conclusions
The present study has demonstrated that the tissue spon-
taneously regenerated in vivo by using the PAMPS/
PDMAAm DN gel can be genetically regarded as the hya-
line cartilage, although it has some minor differences from
the normal cartilage. The expression degree of COL2A1,
COL1A2, COL10A1, DCN, FMOD, SPARC, FLOD2,
CHAD, CTGF, and COMP genes was greater in the regen-
erated tissue than in the normal cartilage. The top 30
g e n e st h a te x p r e s s e d5t i m e so rm o r ei nt h er e g e n e r a t e d
tissue as compared with the normal cartilage included
type-2 collagen, type-10 collagen, FN, vimentin, COMP,
EF-1 alpha, TFCP2, and GAPDH genes. The genetic data
shown in this study are useful for future studies to identify
specific genes involved in spontaneous cartilage regenera-
tion and to make their mechanisms clear.
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